Cargando…
Targeting the Highly Expressed microRNA miR-146b with CRISPR/Cas9n Gene Editing System in Thyroid Cancer
Thyroid cancer is the most common endocrine malignancy, and the characterization of the genetic alterations in coding-genes that drive thyroid cancer are well consolidated in MAPK signaling. In the context of non-coding RNAs, microRNAs (miRNAs) are small non-coding RNAs that, when deregulated, coope...
Autores principales: | de Santa-Inez, Daniel Casartelli, Fuziwara, Cesar Seigi, Saito, Kelly Cristina, Kimura, Edna Teruko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348963/ https://www.ncbi.nlm.nih.gov/pubmed/34360757 http://dx.doi.org/10.3390/ijms22157992 |
Ejemplares similares
-
Gene Editing with CRISPR/Cas Methodology and Thyroid Cancer: Where Are We?
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2022) -
MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2014) -
Interplay of TGFβ signaling and microRNA in thyroid cell loss of differentiation and cancer progression
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2019) -
How does microRNA modulate Wnt/β-catenin signaling in thyroid oncogenesis?
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2020) -
Insights into Regulation of the miR-17-92 Cluster of miRNAs in Cancer
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2015)